ALS Clinical Trial - rTMS in Treatment of Spasticity

Status Terminated

Clinical Trial Summary

This is an open-label clinical trial to determine the safety and efficacy of rTMS in reducing spasticity and improving quality of life among patients with upper motor neuron predominant motor neuron disease (MND).

Clinical Trial Description

The study's objective is to evaluate the role of rTMS for symptom reduction of spasticity among patients with upper motor neuron predominant motor neuron disease. This study is 12-week open label safety and efficacy trial. A total of 10 subjects with PLS and UMN/ MND will be enrolled in this study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04054141
Study type	Interventional
Source	Hospital for Special Surgery, New York
Contact
Status	Terminated
Phase	N/A
Start date	September 1, 2018
Completion date	August 16, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04948645` - A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis	Phase 1
Completed	`NCT02405182` - MRI Biomarkers in ALS
Completed	`NCT00696332` - Talampanel for Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Recruiting	`NCT03865420` - Amyotrophic Lateral Sclerosis (ALS) Families Project
Recruiting	`NCT03272503` - A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Completed	`NCT05568615` - Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS	Phase 3
Recruiting	`NCT05635266` - A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Active, not recruiting	`NCT04259255` - Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
Recruiting	`NCT02495571` - Assessment of Voluntary and Reflex Cough in Patients With ALS	N/A
Completed	`NCT02525471` - A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)	Phase 1
Recruiting	`NCT05031351` - NF-κB Inhibition in Amyotrophic Lateral Sclerosis	Phase 2
Active, not recruiting	`NCT05581771` - Factors Associated With Success of NIPPV in ALS Patients
Active, not recruiting	`NCT03268603` - Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)	Phase 2
Recruiting	`NCT05271435` - Digital Tools for Assessment of Motor Functions and Falls in ALS
Completed	`NCT06005506` - National Multicenter Interventional Study Aimed at Evaluating the Effect on the Intestinal Microbiota in Chronically Frail Patients Who Share Alterations in Intestinal Function.	N/A
Recruiting	`NCT04138095` - Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care	N/A
Recruiting	`NCT03698149` - ECoG BMI for Motor and Speech Control	N/A
Not yet recruiting	`NCT05621213` - Satisfaction of Patients With Amyotrophic Lateral Sclerosis Regarding Home Assisted Teleconsultation	N/A
Terminated	`NCT03373981` - Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS	N/A
Completed	`NCT04165850` - Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS	Phase 2